| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 745591 | Null | 0.0382675857669585 | 0.057282963 |
| NSC 746701 | N-(4-Chlorophenyl)-N-({[2-(4-chlorophenyl)ethyl]amino]carbonothioyl)benzamide | 0.0382675857669585 | 0.21819487 |
| NSC 749117 | 3-(2-Hydroxy-4-methoxyphenyl)-5-(4-methoxyphenyl)-1-(4-sulfamylphenyl)-2-pyrazoline | 0.0382675857669585 | 0.394194 |
| NSC 754081 | 7-(4-methoxybenzyl)-4,4-dimethyl-6-phenyl-5,7-dihydro-4H-isoxazolo[5,4-e]isoindole | 0.0382675857669585 | 0.39419814 |
| NSC 756134 | GSK1023156A | 0.0382675857669585 | 0.13683301 |
| NSC 760978 | Null | 0.0382675857669585 | 0.069971082 |
| NSC 764037 | BP-1-102 | 0.0382675857669585 | 0.022199395 |
| NSC 111702 | p-Dioxane-2-methanol, 3,5-dihydroxy-6-[6-(methylthio)-9H-purin-9-yl]- | 0.0382675857669588 | 0.35818681 |
| NSC 125845 | Null | 0.0382675857669588 | 0.31395749 |
| NSC 133072 | Ethanesulfonic acid, compd. with 4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)-m-hydrocinnamotoluidide (1:1) | 0.0382675857669588 | 0.24013085 |